Altrinsic Global Advisors LLC Kura Oncology, Inc. Transaction History

Altrinsic Global Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $1.3 Million - $1.87 Million	-110,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $308,400 - $434,400	20,000 Added 22.22%	110,000 $2.06 Million
Q2 2021 Aug 13, 2021	BUY	$20.85 - $29.88 $417,000 - $597,600	20,000 Added 28.57%	90,000 $1.88 Million
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $123,750 - $195,700	-5,000 Reduced 6.67%	70,000 $1.98 Million
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $725,000 - $1.04 Million	-25,000 Reduced 25.0%	75,000 $2.45 Million
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $163,000 - $306,400	-10,000 Reduced 9.09%	100,000 $3.06 Million
Q1 2020 May 14, 2020	BUY	$6.45 - $14.04 $129,000 - $280,800	20,000 Added 22.22%	110,000 $1.1 Million
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $73,750 - $104,350	-5,000 Reduced 5.26%	90,000 $1.37 Million
Q2 2019 Aug 14, 2019	SELL	$14.71 - $19.79 $147,100 - $197,900	-10,000 Reduced 9.52%	95,000 $1.87 Million
Q4 2018 Feb 14, 2019	BUY	$10.6 - $17.49 $265,000 - $437,249	25,000 Added 31.25%	105,000 $1.47 Million
Q1 2018 May 14, 2018	BUY	$14.5 - $23.4 $290,000 - $468,000	20,000 Added 33.33%	80,000 $1.5 Million
Q3 2017 Nov 14, 2017	BUY	$6.05 - $14.95 $363,000 - $897,000	60,000	60,000 $897,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.